FDA Announces Workshop on Possible Mandatory Opioid Prescriber Education
The FDA, in partnership with the Duke-Margolis Center for Health Policy, will hold a two-day virtual public workshop on potentially requiring prescribers of opioids to complete education as part of a Risk Evaluation and Mitigation Strategy.
Comment
expand_more
expand_less